Ind-Swift Laboratories to incorporate wholly owned subsidiary in UAE

19 Apr 2024 Evaluate

Ind-Swift Laboratories has received approval to incorporate wholly owned subsidiary (WOS) in Dubai, United Arab Emirates (UAE) in the name and style of ‘Ind-Swift (Dubai)’ or such other name as may be approved by the concerned authorities of the UAE. 

The WOS intends to strategically invest in pharmaceutical and allied activities. This includes exploring potential acquisitions, tie-ups, or joint ventures. Additionally, the Company aims to establish and operate pharmaceutical manufacturing units. The investment in the wholly owned subsidiary would be a Related Party Transaction. The investment shall be made on arms’ Length basis.

Ind-Swift Laboratories is global manufacturer of Active Pharmaceutical Ingredients (API), Intermediates and formulations (through group collaboration).


Ind-Swift Lab. Share Price

111.55 1.25 (1.13%)
08-May-2024 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.00
Dr. Reddys Lab 6050.00
Cipla 1383.40
Zydus Lifesciences 1006.10
Lupin 1616.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.